Clinical Trial Update: Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B [Phase 3]

View source ↗

Summary

Phase 3 study comparing on-demand Factor IX treatment with two prophylaxis regimens in patients with severe Hemophilia B; results from the completed trial were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• BeneFIX (recombinant coagulation factor IX concentrate)

Snippet

Sponsor: Pfizer | Conditions: Hemophilia B | Phase 3 | Status: COMPLETED | Results posted: 2011-08-23